Stock Events

Stock Events

Viking Therapeutics (VKTX) Q1 2026 Earnings

11FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-1.38

-1.03

-0.68

-0.33

Details

Expected EPS

-0.890244

Actual EPS

-1.38

Surprise EPS

-0.49

Surprise Percent

+55.01%

Description

Viking Therapeutics (VKTX) has reported earnings of -1.38 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.